Welcome to Penn's TMS Treatment Program
The Transcranial Magnetic Stimulation (TMS) Treatment Program at The University of Pennsylvania offers a non-invasive, outpatient-based form of brain stimulation therapy for mood disorders. TMS has proven effectiveness as a treatment for depression and is approved by the US Food and Drug Administration (FDA). TMS is a safe procedure and lacks side effects that are common with antidepressants and other psychopharmacologic agents.
The TMS program at the University of Pennsylvania is one of the leading treatment centers in the US with more than a decade of clinical experience with TMS. Based in the outpatient treatment facility of the Department of Psychiatry of The University of Pennsylvania at 3535 Market Street, our TMS center is directed by experts on mood disorders and neuromodulation to ensure adequacy of treatment and to maximize chances of treatment response. The treatment is administered within The University of Pennsylvania medical campus following safety standards to minimize the risk of complications.
Members of the Clinical Transcranial Magnetic Stimulation Society, the International Society for Electroconvulsive Therapy and Neurostimulation, and the National Network of Depression Centers.